{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:43:22Z","timestamp":1780505002521,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.063","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T18:42:43Z","timestamp":1630176163000},"page":"5839-5844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Estimating Bordetella pertussis seroprevalence in adolescents and young adults in Mexico using the 2012 National Health and Nutrition Survey (ENSANUT)"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-0168","authenticated-orcid":false,"given":"G.","family":"Echaniz-Aviles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Garc\u00eda-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"S\u00e1nchez-Alem\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Olamendi-Portugal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Romero-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Deantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Y.","family":"Cervantes-Apolinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ortega-Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cortes-Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Alpuche-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.063_b0005","unstructured":"Centers for Disease Control and Prevention. Pertussis - Causes and Transmission (2017) [Accessed 10\/23\/2017]; Available from: https:\/\/www.cdc.gov\/pertussis\/about\/causes-transmission.html."},{"key":"10.1016\/j.vaccine.2021.08.063_b0010","unstructured":"World Health Organization. Pertussis (2011) [Accessed 19-03-2018]; Available from: http:\/\/www.who.int\/immunization\/topics\/pertussis\/en\/."},{"key":"10.1016\/j.vaccine.2021.08.063_b0015","unstructured":"World Health Organization. Pertussis (2019) [Accessed 19-07-2021]; Available from: https:\/\/www.who.int\/health-topics\/pertussis#tab=tab_1."},{"key":"10.1016\/j.vaccine.2021.08.063_b0020","unstructured":"Carrada Bravo T, Gomez Orozco J, Luna Martinez J, et al. [Whooping cough and pertussis vaccination. Report in commemoration of the 40th anniversary of pertussis vaccination in Mexico, 13 June 1940]. Salud publica de Mexico. 24(4):399-465.(1982)."},{"key":"10.1016\/j.vaccine.2021.08.063_b0025","unstructured":"Consejo Nacional de Vacunacion. Manual de Vacunacion 2008-2009 [Pdf]. M\u00e9xico: Centro Nacional para la Salud de la Infancia y la Adolescencia; 2008. Available from: http:\/\/www.censia.salud.gob.mx\/contenidos\/descargas\/vacunas\/Manual_Vacunacion2008-2009b.pdf."},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.063_b0030","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4161\/hv.6.11.13077","article-title":"The global pertussis initiative: meeting report from the Regional Latin America Meeting, Costa Rica, 5\u20136 December, 2008","volume":"6","author":"Ulloa-Gutierrez","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2021.08.063_b0035","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2017 global summary - Mexico (2017) [Accessed 10\/23\/2017]; Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=MEX&commit=OK."},{"issue":"5 Suppl","key":"10.1016\/j.vaccine.2021.08.063_b0040","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.08.063_b0045","doi-asserted-by":"crossref","unstructured":"Guiso N, Wirsing von Konig CH, Forsyth K, et al. The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. Vaccine. 29(6):1115\u201321.(2011).","DOI":"10.1016\/j.vaccine.2010.12.010"},{"issue":"19","key":"10.1016\/j.vaccine.2021.08.063_b0050","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.vaccine.2010.02.104","article-title":"The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection","volume":"28","author":"Rendi-Wagner","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.063_b0055","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1586\/14760584.7.10.1569","article-title":"Pertussis in Latin America: current situation and future vaccination challenges","volume":"7","author":"Ulloa-Gutierrez","year":"2008","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2021.08.063_b0060","unstructured":"Sistema \u00danico de Informaci\u00f3n para la Vigilancia Epidemiol\u00f3gica\/Direcci\u00f3n General de Epidemiolog\u00eda\/SSA. Distribuci\u00f3n de los casos nuevos de enfermedades por grupo de edad, Estados Unidos M\u00e9xicanos, 2006 Poblaci\u00f3n General (2006) [Accessed 19-03-2018]; Available from: http:\/\/www.epidemiologia.salud.gob.mx\/anuario\/2006\/morbilidad\/nacional\/distribucion_casos_nuevos_enfermedad_grupo_edad.pdf."},{"key":"10.1016\/j.vaccine.2021.08.063_b0065","unstructured":"Sistema \u00danico de Informaci\u00f3n para la Vigilancia Epidemiol\u00f3gica\/Direcci\u00f3n General de Epidemiolog\u00eda\/SSA. Distribuci\u00f3n de casos nuevos de enfermedad por grupos de edad, Estados Unidos Mexicanos, 2015 Poblaci\u00f3n General (2016) [Accessed 19-03-2018]; Available from: http:\/\/www.epidemiologia.salud.gob.mx\/anuario\/2015\/morbilidad\/nacional\/distribucion_casos_nuevos_enfermedad_grupo_edad.pdf."},{"key":"10.1016\/j.vaccine.2021.08.063_b0070","doi-asserted-by":"crossref","unstructured":"Beltran Silva S, Cervantes Apolinar Y, Cherry JD, et al. [Consensus on the clinical and microbiologic diagnosis of Bordetella pertussis, and infection prevention. Expert Group on Pertussis Vaccination]. Salud publica de Mexico. 53(1):57-65.(2011).","DOI":"10.1590\/S0036-36342011000100009"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.063_b0075","doi-asserted-by":"crossref","first-page":"ftv050","DOI":"10.1093\/femspd\/ftv050","article-title":"Seroprevalence studies of pertussis: what have we learned from different immunized populations","volume":"73","author":"Barkoff","year":"2015","journal-title":"Pathog Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.063_b0080","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.vaccine.2015.12.036","article-title":"Seroprevalence of pertussis amongst healthcare professionals in Spain","volume":"34","author":"Rodr\u00edguez de la Pinta","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.063_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148338","article-title":"Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination","volume":"11","author":"Wanlapakorn","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.063_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035874","article-title":"Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia","volume":"7","author":"Campbell","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.063_b0095","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.063_b0100","unstructured":"Guti\u00e9rrez J, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrici\u00f3n 2012. Resultados Nacionales [pdf]. Cuernavaca, M\u00e9xico: Instituto Nacional de Salud P\u00fablica; 2012. Available from: https:\/\/ensanut.insp.mx\/encuestas\/ensanut2012\/doctos\/informes\/ENSANUT2012ResultadosNacionales.pdf."},{"issue":"suppl 2","key":"10.1016\/j.vaccine.2021.08.063_b0105","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.21149\/spm.v55s2.5133","article-title":"Household socioeconomic classification in the National Health and Nutrition Survey 2012","volume":"55","author":"Guti\u00e9rrez","year":"2013","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.vaccine.2021.08.063_b0110","doi-asserted-by":"crossref","unstructured":"Romero-Mart\u00ednez M, Shamah-Levy T, Franco-Nunez A, et al. Encuesta Nacional de Salud y Nutrici\u00f3n 2012: dise\u00f1o y cobertura. Salud publica de Mexico [Internet]. 2013 08-Jan-2020; 55(Suppl 2):[s332-40 pp.]. Available from: https:\/\/pdfs.semanticscholar.org\/24f4\/d26451fdd4e338ae875707cdbf6ac66f71ac.pdf.","DOI":"10.21149\/spm.v55s2.5132"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.063_b0115","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/CVI.00248-09","article-title":"Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection","volume":"16","author":"Menzies","year":"2009","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2021.08.063_b0120","unstructured":"Euroimmun Medizinische Labordiagnostika AG. Anti-Bordetella Pertussis Toxin ELISA IgG Test instruction."},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.063_b0125","first-page":"1045","article-title":"Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States","volume":"11","author":"Baughman","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.063_b0130","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/JCM.01371-10","article-title":"Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis","volume":"48","author":"Riffelmann","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.08.063_b0135","unstructured":"Genzyme Virotech GmbH. Pertussis Toxin ELISA IgG Testkit \/ IgA Testkit. 2008."},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.063_b0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1017\/S0950268813001313","article-title":"Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study","volume":"142","author":"Conde-Glez","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.08.063_b0145","unstructured":"Secretary of Health. Official record of National Council of Vaccination meeting, April 24. Mexico; 2012."},{"key":"10.1016\/j.vaccine.2021.08.063_b0150","unstructured":"Secretaria de Salud. Vacunaci\u00f3n en la Embarazada [pdf]. Mexico: Secretaria de Salud; 2010. Available from: http:\/\/www.cenetec.salud.gob.mx\/descargas\/gpc\/CatalogoMaestro\/580_GPC_Vacunacixnenlaembarazada\/580GER.pdf."},{"key":"10.1016\/j.vaccine.2021.08.063_b0155","unstructured":"Secretaria de Salud. NORMA Oficial Mexicana NOM-036-SSA2-2012, Prevenci\u00f3n y control de enfermedades. Aplicaci\u00f3n de vacunas, toxoides, faboter\u00e1picos (sueros) e inmunoglobulinas en el humano. [pdf]. Mexico2012. Available from: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/53622\/NOM-036-SSA2-2012.pdf."},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.063_b0160","first-page":"164","article-title":"[Pertussis in Mexico, an epidemiological overview. A study of 19 years at the Instituto Mexicano del Seguro Social]","volume":"53","author":"Perez-Perez","year":"2015","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"10.1016\/j.vaccine.2021.08.063_b0165","first-page":"314","article-title":"Tos ferina, un problema vigente de salud p\u00fablica en M\u00e9xico: Planteamiento de la necesidad para introducir una nueva vacuna","volume":"69","author":"Su\u00e1rez-Idueta","year":"2012","journal-title":"Bolet\u00edn m\u00e9dico del Hospital Infantil de M\u00e9xico"},{"key":"10.1016\/j.vaccine.2021.08.063_b0170","doi-asserted-by":"crossref","unstructured":"Son S, Thamlikitkul V, Chokephaibulkit K, et al. Prospective multinational serosurveillance study of Bordetella pertussis infection among 10- to 18-year-old Asian children and adolescents. Clin Microbiol Infect 2019;25(2):250:e1-e7.","DOI":"10.1016\/j.cmi.2018.04.013"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.063_b0175","first-page":"e15","article-title":"Evaluation of commercial assays for single-point diagnosis of pertussis in the US","volume":"6","author":"Pawloski","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.063_b0180","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CMR.00031-15","article-title":"Laboratory diagnosis of pertussis","volume":"28","author":"van der Zee","year":"2015","journal-title":"Clin Microbiol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:45Z","timestamp":1759402905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":36,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21011117"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating Bordetella pertussis seroprevalence in adolescents and young adults in Mexico using the 2012 National Health and Nutrition Survey (ENSANUT)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}